Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescents
Nicole R. Florance(Children's Hospital of Philadelphia), Josep Dalmau(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Amy J. Gleichman(Pediatrics and Genetics), Myrna R. Rosenfeld(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Saba Ahmad(Children's Hospital of Philadelphia), Christopher Wai Kei Lam(Children's Hospital of Philadelphia), Nadja G. Peter(Children's Hospital of Philadelphia), Christina L. Szperka(Children's Hospital of Philadelphia), Heather E. Moss(University of Pennsylvania), Lei Zhou(University of Pennsylvania), Rebecca Davis(University of Pennsylvania), David R. Lynch(Pediatrics and Genetics), Carol Glaser(University of California, San Francisco), Cynthia Campen(Children's Hospital of Philadelphia)
Cited by 1,097
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
|The Lancet Neurology|2008|3.5k
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
|The Lancet Neurology|2013|3.1k
Paraneoplastic anti– <i>N</i> ‐methyl‐ <scp>D</scp> ‐aspartate receptor encephalitis associated with ovarian teratoma
|Annals of Neurology|2007|2.5k
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
|The Lancet Neurology|2010|2.4k